| Name: | Fingolimod Stearate Amide Impurity |
| Catalogue No. | VL1270006 |
| CAS No. | 1242271-27-7 |
| Molecular Formula | C₃₇H₆₇NO₃ |
| Molecular Weight | 573.93 |
| Status | In-stock |
| IUPAC Name | N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)stearamide |
| Appearance | White Powder |
| Description | Fingolimod Stearate Amide Impurity (CAS No. 1242271-27-7) or N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)stearamide is an impurity of Fingolimod. Fingolimod is an Associate in Nursing immunomodulating medication, principally used for treating multiple sclerosis. Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to Associate in Nursing reaction. |
| References | “Sci-Hub | Fingolimod Treatment in Multiple Sclerosis Leads to Increased Macular Volume. Neurology, 80(2), 139–144 | 10.1212/WNL.0b013e31827b9132.” Sci-Hub.se, 2012, sci-hub.se/n.neurology.org/content/80/2/139.short. |
